Ewan Lorna C, Jopling Helen M, Jia Haiyan, Mittar Shweta, Bagherzadeh Azadeh, Howell Gareth J, Walker John H, Zachary Ian C, Ponnambalam Sreenivasan
Endothelial Cell Biology Unit, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, UK
Traffic. 2006 Sep;7(9):1270-82. doi: 10.1111/j.1600-0854.2006.00462.x.
The human endothelial vascular endothelial growth factor receptor 2 (VEGFR2/kinase domain region, KDR/fetal liver kinase-1, Flk-1) tyrosine kinase receptor is essential for VEGF-mediated physiological responses including endothelial cell proliferation, migration and survival. How VEGFR2 kinase activation and trafficking are co-coordinated in response to VEGF-A is not known. Here, we elucidate a mechanism for endothelial VEGFR2 response to VEGF-A dependent on constitutive endocytosis co-ordinated with ligand-activated ubiquitination and proteolysis. The selective VEGFR kinase inhibitor, SU5416, blocked the endosomal sorting required for VEGFR2 trafficking and degradation. Inhibition of VEGFR2 tyrosine kinase activity did not block plasma membrane internalization but led to endosomal accumulation. Lysosomal protease activity was required for ligand-stimulated VEGFR2 degradation. Activated VEGFR2 codistributed with the endosomal hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs)/signal-transducing adaptor molecule (STAM) complex in a ligand and time-dependent manner, implying a role for this factor in sorting of ubiquitinated VEGFR2. Increased tyrosine phosphorylation of the Hrs subunit in response to VEGF-A links VEGFR2 activation and Hrs/STAM function. In contrast, VEGFR2 in quiescent cells was present on both the endothelial plasma membrane and early endosomes, suggesting constitutive recycling between these two compartments. This pathway was clathrin-linked and dependent on the AP2 adaptor complex as the A23 tyrphostin inhibited VEGFR2 trafficking. We propose a mechanism whereby the transition of endothelial VEGFR2 from a constitutive recycling itinerary to a degradative pathway explains ligand-activated receptor degradation in endothelial cells. This study outlines a mechanism to control the VEGF-A-mediated response within the vascular system.
人类内皮血管内皮生长因子受体2(VEGFR2/激酶结构域区域,KDR/胎儿肝激酶-1,Flk-1)酪氨酸激酶受体对于VEGF介导的生理反应至关重要,包括内皮细胞增殖、迁移和存活。目前尚不清楚VEGFR2激酶激活和运输如何响应VEGF-A而协同协调。在这里,我们阐明了一种内皮VEGFR2对VEGF-A的反应机制,该机制依赖于与配体激活的泛素化和蛋白水解协同协调的组成型内吞作用。选择性VEGFR激酶抑制剂SU5416阻断了VEGFR2运输和降解所需的内体分选。抑制VEGFR2酪氨酸激酶活性并未阻止质膜内化,但导致内体积累。溶酶体蛋白酶活性是配体刺激的VEGFR2降解所必需的。激活的VEGFR2以配体和时间依赖性方式与内体肝细胞生长因子调节的酪氨酸激酶底物(Hrs)/信号转导衔接分子(STAM)复合物共分布,这意味着该因子在泛素化VEGFR2的分选中起作用。响应VEGF-A,Hrs亚基酪氨酸磷酸化增加,将VEGFR2激活与Hrs/STAM功能联系起来。相比之下,静止细胞中的VEGFR2存在于内皮质膜和早期内体上,表明这两个区室之间存在组成型循环。该途径与网格蛋白相关,并且依赖于AP2衔接复合物,因为A23 tyrphostin抑制VEGFR2运输。我们提出了一种机制,即内皮VEGFR2从组成型循环行程向降解途径的转变解释了内皮细胞中配体激活的受体降解。这项研究概述了一种控制血管系统内VEGF-A介导反应的机制。